Hui Song

2.2k total citations
69 papers, 1.7k citations indexed

About

Hui Song is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hui Song has authored 69 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Immunology. Recurrent topics in Hui Song's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and Galectins and Cancer Biology (7 papers). Hui Song is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and Galectins and Cancer Biology (7 papers). Hui Song collaborates with scholars based in China, United States and Sweden. Hui Song's co-authors include Jiayuh Lin, Renxiao Wang, Shaomeng Wang, Jue Yang, Xiaobo Lv, Tao Xi, Lin Kang, Xiaobo Zhou, Yingying Xing and Xiaohong Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Hui Song

64 papers receiving 1.7k citations

Peers

Hui Song
Comparison fields: 5 of 113
  • Molecular Biology 847
  • Oncology 603
  • Cancer Research 403
  • Immunology 261
  • Pathology and Forensic Medicine 183
Replace Ivy Chung with:
Ivy Chung Malaysia
Ye Li China
Christopher M. Hope Australia
Yuehua Huang China
Olga Sukocheva Australia
Alvin H.K. Cheung Hong Kong
Sarah M. Planchon United States
Patricia Hess United States
Ching‐Feng Chiu Taiwan
Ivy Chung Malaysia View profile →
Citations per field, relative to Hui Song
Hui Song · 1×
Citations per year, relative to Hui Song
Hui Song · 1×

Countries citing papers authored by Hui Song

Since Specialization
Citations

This map shows the geographic impact of Hui Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Song more than expected).

Fields of papers citing papers by Hui Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Song. The network helps show where Hui Song may publish in the future.

Co-authorship network of co-authors of Hui Song

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Song. A scholar is included among the top collaborators of Hui Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Song. Hui Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 33
4 4
5 5
6 6
7 9
8 9
9 29
10 33
11 37
12 27
13 1
14 21
15 21
16 23
17 14
18
Surgical Treatment for Liver Metastasis from Colorectal Cancer
2
19 125
20 44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026